Blue Jet Healthcare Limited (BLUEJET.NS)
INR 762.2
(1.99%)
INR 762.2
(1.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.15 Billion INR | 16.87% |
| 2022 | 2.7 Billion INR | -8.85% |
| 2021 | 2.96 Billion INR | 19.84% |
| 2020 | 2.47 Billion INR | -24.5% |
| 2019 | 3.27 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.18 Billion INR | 39.41% |
| 2024 Q1 | 708.22 Million INR | -6.96% |
| 2023 Q2 | 832.52 Million INR | 16.43% |
| 2023 Q3 | 750.33 Million INR | -9.87% |
| 2023 Q1 | 715.02 Million INR | -33.89% |
| 2023 Q4 | 761.23 Million INR | 1.45% |
| 2023 FY | 3.15 Billion INR | 16.87% |
| 2022 Q1 | 501.15 Million INR | 0.0% |
| 2022 FY | 2.7 Billion INR | -8.85% |
| 2022 Q4 | 1.08 Billion INR | 16.33% |
| 2022 Q3 | 929.67 Million INR | -6.1% |
| 2022 Q2 | 990.06 Million INR | 97.56% |
| 2021 FY | 2.96 Billion INR | 19.84% |
| 2020 FY | 2.47 Billion INR | -24.5% |
| 2019 FY | 3.27 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Biocon Limited | 91.73 Billion INR | 96.556% |
| Concord Biotech Limited | 7.56 Billion INR | 58.236% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 35.576% |
| Jubilant Ingrevia Limited | 9.16 Billion INR | 65.533% |
| Lyka Labs Limited | 145.95 Million INR | -2064.554% |
| Panacea Biotec Limited | 1.42 Billion INR | -121.28% |
| Piramal Pharma Limited | 24.47 Billion INR | 87.09% |
| SMS Lifesciences India Limited | 329.57 Million INR | -858.568% |
| Supriya Lifescience Limited | 2.65 Billion INR | -19.135% |
| Syngene International Limited | 12.43 Billion INR | 74.6% |
| TAKE Solutions Limited | 183.42 Million INR | -1622.391% |
| Zota Health Care Limited | 332.52 Million INR | -850.061% |